Skip to contentC
Chemed Corp
C
CHEChemed Corp Q1 2022 · 10-Q
Revenue$299.19M$299.19M−5.3% vs Q1 2021 Net Income$64.17M$64.17M−1.9% vs Q1 2021 EPS Diluted$4.22$4.22+5.2% vs Q1 2021 Operating Income$89,374,000+11.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Free Cash Flowderived$88,441,000−0.7% Margins · derivedOperating margin29.9%+4.4 pt vs Q1 2021
Net margin21.4%+0.7 pt vs Q1 2021
ended Mar 31, 2022 · filed Apr 29, 2022 · 29 d after period end